Exogenous hydrogen sulfide inhibits oral mucosal wound-induced macrophage activation via the NF-κB pathway.

The exogenous H2 S donor GYY4137 compensated for the reduced endogenous H2 S postmucosal wound generation and inhibited the induced M1 macrophage activation. Thus, appropriate H2 S supplementation may aid in controlling inflammation associated with mucosal wounds.